Eldorado Gold Corp (ELD)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 44.32 |
|---|---|
| 52-week range | 34.25 – 69.46 |
| Return, 1 month / 3 months | −26.7% / −1.4% |
| Return, 1 year / 3 years | +21.4% / +217.7% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 58.2% |
| Worst drawdown (1 year) | -42.1% |
| Average daily value traded | 47.75M CAD |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eldorado Gold is a gold mining company based in Vancouver, Canada. It explores for, develops and operates gold mines, producing gold in doré bars and concentrates from operations that include mines in Turkey and Greece, along with projects in Canada and other regions. Its customers are mainly refiners and metals traders who handle precious metals. The company also carries out exploration and mine development work around its existing sites and at earlier-stage properties.
On this site Eldorado Gold Corp appears as a stock on the Toronto Exchange (Canada), code ELD, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eldorado Gold Corp (ELD) trades on the Toronto Exchange in Canada. It last closed at CAD 44.32 on 23 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 470 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.4% and over the last three months it fell 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.4% | ||
| From 52-week high | -34.3% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.4% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 65.7% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.1% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 47.75M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 7 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −12.8% |
|---|---|
| 1 month | −26.7% |
| 3 months | −1.4% |
| 6 months | +2.7% |
| 1 year | +21.4% |
| 3 years | +217.7% |
| 5 years | +273.3% |
Signals
| 50-day / 200-day average | 56.79 / 51.18 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | CAD 0.1040 |
| 2 Jun 2026 | CAD 0.1040 |
| 27 Feb 2026 | CAD 0.1030 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.